The Global Pharmaceutical Grade Lactose Market size was estimated at USD 0.13 billion in 2022 and is expected to hit around USD 0.19 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 4.67% from 2022 to 2030.
Global Pharmaceutical Grade Lactose Market: Breakup by Region, 2022 & 2031
Source: Primary Research and Secondary Research Analysis
Pharmaceutical grade lactose is a highly purified kind of lactose that satisfies the exacting quality and purity requirements necessary for usage in food and pharmaceutical applications. It is often created from milk or whey and goes through a lot of processing to get rid of pollutants and impurities. In the manufacturing of numerous pharmaceutical products, including tablets, capsules, and powders, pharmaceutical grade lactose is frequently employed as a bulking agent, filler, and diluent. It also has a wide range of additional uses, including in the food and cosmetics sectors. The amount of moisture, reducing sugars, and ash in pharmaceutical grade lactose are commonly used to determine how pure it is. It must adhere to tight specifications for these factors as well as for chemical and microbiological purity.
Throughout the upcoming years, a significant pace of growth in the global market for pharmaceutical grade lactose is anticipated. The demand for pharmaceuticals and medications is fueling the expansion of the pharmaceutical grade lactose market, which is a commonly utilised ingredient in the pharmaceutical industry. The need for lactose-based excipients, which are utilised as fillers, binders, and diluents in the manufacture of tablets, capsules, and other dosage forms, is another factor driving the market. Because to their low cost, convenient availability, and superior physicochemical qualities, lactose-based excipients are chosen.
DFE Pharma, Meggle AG, Armor Pharma, BASF SE, Kerry Group, Merck KGaA, and VM Fonterra Excipients are a few of the major companies in the worldwide pharmaceutical grade lactose market. These businesses are increasing their manufacturing capabilities to keep up with the rising demand for pharmaceutical grade lactose while also investing in R&D initiatives to enhance the functionality and quality of their goods.
The global market for pharmaceutical grade lactose has seen a mixed response to the COVID-19 outbreak. On the one hand, the global effort to treat and contain the virus has increased demand for pharmaceutical supplies. This has led to a rise in the demand for pharmaceutical-grade lactose, an excipient used in the manufacturing of a variety of drugs.
On the other hand, the pandemic has hampered global supply chains, caused delays in manufacturing and shipping, and reduced the supply of both raw materials and finished goods. The market for pharmaceutical grade lactose has seen a few brief hiccups as a result.
The pharmaceutical grade lactose business, however, has demonstrated resiliency and has been expanding during the epidemic, despite these difficulties. As the world recovers from the pandemic and the need for pharmaceutical products keeps rising, the market is anticipated to bounce back and expand at a steady rate.
Also, as manufacturers strive to assure the safety and efficacy of their goods, the pandemic has led to a rise in awareness of the significance of high-quality and secure pharmaceutical products, which is anticipated to raise demand for pharmaceutical grade lactose.
In summary, pharmaceutical grade lactose is a crucial component in the pharmaceutical sector, assisting in ensuring the safety and efficacy of a variety of drugs and other products.
Global Pharmaceutical Grade Lactose Market Research Report, 2020-2031.
Table of Contents
Our reports with in-depth insights will equip you to succeed in your business plans.
Get instant access to the information you need to make the right decision.
Explore where opportunities lie for you and mitigate the risks.
We are one of the most trusted brands setting benchmarks of excellence.